| |
Ecron Acunova – Synergy of Regional Experts
Ecron Acunova combines the strengths from two expert CROs on two continents serving established clinical research geographies. This entity is led by Ecron’s experience of more than 20 years, strengthened by the reputed CRO Acunova. This integration enabled the two expert CRO’s to increase the value to sponsors with patient recruitment in India, West Europe and East Europe and data management from India and Europe with faster patient enrolment in clinical trials, timely database lock, high quality early phase development as well as unique features like access to the central lab for clinical trial testing. These services bring speed to projects, are of high quality and improve our performance, addressing sponsor’s needs. |
 |
| |
|
|
|
Manipal Acunova
A venture promoted by Manipal Education and Medical Group and Acunova Life Sciences. Mr. D.A. Prasanna is the founder, whose experience in the healthcare sector is acknowledged and is known for leveraging Asian competitiveness to build a successful global business. Manipal Acunova provides phase I – IV clinical development services including project management, CDM, biostatistics, medical writing, BA/BE & central lab. With research facilities in Bangalore, Mangalore and Manipal, Manipal Acunova is a CRO with preferred access to Manipal Medical University’s 19 teaching hospitals.
Reputation for quality is built around people and processes are ISO 15189 certified for medical testing, ISO 9001 for managerial requirements & ISO 27001 for information security. The labs in Bangalore and Manipal are CAP compliant and ISO certified. The phase I facility has been audited by US FDA. The company has been recognised as India’s No 1 emerging CRO by Proximare Inc. of New Jersey. |
|
Ecron
The brainchild of Dr Klaus Wiedey was founded in Constance, Germany, in 1986 and was previously known as Dr Wiedey GmbH. Gradual expansion has led to the formation of Ecron and a group with Europe-wide presence.
Ecron, with an enviable reputation for quality, is a European expert CRO for the clinical development of drugs, devices and diagnostics for human use. Headquartered in Frankfurt, Germany, Ecron has conducted trials for submission to European and US authorities. Ecron’s studies have been audited by both FDA and European Regulators. Ecron affiliates run operations in Germany, Ukraine, Spain, UK, Italy, Poland and the Czech Republic. Further locations are accessible through our dedicated and harmonised partners in other countries in Europe and abroad. |
|
| |
|
|
|
Customer Focused Capabilities
Ecron Acunova has the necessary infrastructure to execute any phase of clinical trials in all key therapeutic areas.
The company has built global reputation of managing diagnostic contrast agent studies, stem cell therapy studies and PK/PD services. Studies have been successfully audited by global regulators like WHO and US FDA. The team is experienced in combining its competency in PK/PD, lab, imaging and project management to conduct early to late stage development trials for innovator companies.
|
|
Growth Drivers
Ecron Acunova leverages regional competitive advantage in clinical research by combining the experience and quality standards of West European market with the fast recruitment and cost advantages of the Central and East European markets as well as India. The driving force is the composition of the team and the team’s involvement in various advisory boards. More than 22 MDs, 19 PhDs and 19 physicians with MBBS and BDS, as well as access to highly qualified personnel in Medical Universities in India, Europe and US, benchmark Ecron Acunova as the 'Science CRO'.
The company has grown through alliances in USA and with functional experts like Infosys in CDM, Biotrial in ‘first-in-man’ studies. This has created win-win opportunities and a platform to accelerate ‘pharma time-to-market’. |
 |
|
|
